C4 Therapeutics Inc. (CCCC)
NASDAQ: CCCC
· Real-Time Price · USD
2.27
0.06 (2.71%)
At close: Oct 03, 2025, 3:59 PM
2.27
0.00%
After-hours: Oct 03, 2025, 07:37 PM EDT
C4 Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 6.46M | 7.24M | 5.18M | 15.36M | 12.01M | 3.04M | 3.26M | 11.07M | 2.66M | 3.76M | 2.85M | 6.75M | 13.83M | 7.65M | 20.08M | 8.5M | 9.78M | 7.43M |
Cost of Revenue | n/a | 2.01M | 1.77M | 2.06M | 2.04M | 2.03M | 1.69M | 2M | 1.99M | 2.06M | 2.02M | 1.92M | 2.14M | 1.49M | 758K | 24.3M | 23.29M | 20.53M |
Gross Profit | 6.46M | 7.24M | 3.41M | 13.31M | 9.96M | 1.01M | 1.57M | 9.08M | 675K | 1.7M | 831K | 4.83M | 11.69M | 6.17M | 19.32M | -15.8M | -13.51M | -13.1M |
Operating Income | -28.5M | -29.16M | -37.71M | -28.24M | -21.44M | -32.22M | -37.43M | -27.81M | -37.57M | -36.23M | -38.29M | -32.49M | -27.38M | -31.37M | -15.26M | -24.25M | -22.12M | -20.51M |
Interest Income | 2.48M | 2.84M | 3.27M | 3.58M | 3.73M | 3.86M | 2.95M | 2.56M | 2.25M | 2.05M | 1.71M | 1.08M | 506K | 276K | 136K | 110K | 69K | 72K |
Pretax Income | -26.02M | -26.32M | -34.44M | -24.67M | -17.72M | -28.36M | -34.48M | -26.03M | -35.92M | -34.78M | -37.19M | -31.96M | -27.41M | -31.62M | -15.66M | -24.68M | -22.58M | -20.97M |
Net Income | -26.02M | -26.32M | -34.57M | -24.67M | -17.72M | -28.36M | -34.75M | -27.04M | -35.92M | -33.94M | -36.08M | -31.43M | -27.44M | -31.87M | -15.66M | -24.68M | -22.58M | -20.97M |
Selling & General & Admin | 8.77M | 9.33M | 10.37M | 11.77M | 9.7M | 10.29M | 8.61M | 10.53M | 10.31M | 10.95M | 10.49M | 9.58M | 9.89M | 12.82M | 8.78M | 8.45M | 8.61M | 7.41M |
Research & Development | 26.2M | 27.07M | 32.51M | 31.84M | 23.75M | 22.53M | 30.39M | 28.35M | 29.93M | 29.04M | 30.65M | 29.66M | 31.32M | 26.2M | 26.55M | 24.3M | 23.29M | 20.53M |
Other Expenses | -2.08M | n/a | -1.77M | -2.06M | -2.04M | -20.1M | n/a | -2M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 32.88M | 36.4M | 41.12M | 41.55M | 31.4M | 12.72M | 39M | 36.88M | 40.23M | 39.99M | 41.15M | 39.24M | 41.22M | 39.02M | 35.33M | 32.75M | 31.9M | 27.93M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 167K | 600K | 606K | 601K | 554K | 534K | 527K | 539K | 539K | 533K | 534K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | -1.69M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 34.96M | 36.4M | 42.89M | 43.61M | 33.45M | 35.26M | 40.69M | 38.88M | 40.23M | 39.99M | 41.15M | 39.24M | 41.22M | 39.02M | 35.33M | 32.75M | 31.9M | 27.93M |
Income Tax Expense | n/a | n/a | 131K | n/a | n/a | -2.03M | 277K | -1M | n/a | -842K | -1.11M | -530K | 28K | 251K | n/a | 110K | 69K | 72K |
Shares Outstanding (Basic) | 71.01M | 70.83M | 70.61M | 69.63M | 68.81M | 68.43M | 51.22M | 49.21M | 49.06M | 49.03M | 48.97M | 48.92M | 48.82M | 48.65M | 48.49M | 48.49M | 43.86M | 43.08M |
Shares Outstanding (Diluted) | 71.01M | 70.83M | 70.61M | 69.63M | 68.81M | 68.43M | 51.22M | 49.21M | 49.06M | 49.03M | 48.97M | 48.92M | 48.82M | 48.73M | 48.49M | 48.49M | 43.86M | 43.08M |
EPS (Basic) | -0.37 | -0.37 | -0.49 | -0.35 | -0.26 | -0.41 | -0.68 | -0.55 | -0.73 | -0.69 | -0.74 | -0.64 | -0.56 | -0.66 | -0.32 | -0.51 | -0.51 | -0.49 |
EPS (Diluted) | -0.37 | -0.37 | -0.49 | -0.35 | -0.26 | -0.41 | -0.68 | -0.55 | -0.73 | -0.69 | -0.74 | -0.64 | -0.56 | -0.65 | -0.32 | -0.51 | -0.51 | -0.49 |
EBITDA | -28.5M | -28.71M | -32.68M | -22.61M | -15.67M | -26.33M | -32.79M | -23.87M | -33.33M | -32.11M | -34.56M | -29.48M | -24.74M | -29.6M | -14.36M | -23.81M | -21.33M | -19.67M |
EBIT | -26.02M | -29.16M | -34.44M | -24.67M | -17.72M | -28.36M | -34.48M | -25.87M | -35.32M | -34.17M | -36.58M | -31.4M | -26.88M | -31.09M | -15.12M | -24.14M | -22.05M | -20.44M |
Depreciation & Amortization | 615K | 456K | 1.77M | 2.06M | 2.04M | 2.03M | 1.69M | 2M | 1.99M | 2.06M | 2.02M | 1.92M | 2.14M | 1.49M | 758K | 663K | 715K | 771K |